Vext Science, Inc.
VEXT
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 59.10% | 37.79% | 21.13% | 10.96% | -8.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 59.10% | 37.79% | 21.13% | 10.96% | -8.27% |
| Cost of Revenue | 24.18% | 31.55% | 23.02% | -5.21% | 5.46% |
| Gross Profit | 213.51% | 70.81% | 14.50% | 41.49% | -41.79% |
| SG&A Expenses | -4.15% | -12.22% | -62.14% | 11.65% | 234.67% |
| Depreciation & Amortization | 6.96% | 8.23% | 7.92% | 22.83% | 110.62% |
| Other Operating Expenses | -- | -- | 37,500.00% | -- | -- |
| Total Operating Expenses | 13.92% | 17.46% | -16.25% | 4.71% | 43.31% |
| Operating Income | 87.31% | 35.23% | 57.34% | 24.79% | -650.35% |
| Income Before Tax | 105.84% | 46.70% | -190.63% | 5.75% | -645.87% |
| Income Tax Expenses | 1,471.65% | 34.45% | -12.60% | 77.56% | 88.87% |
| Earnings from Continuing Operations | 66.33% | 47.36% | -263.73% | -35.83% | -919.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.33% | 47.36% | -263.73% | -35.83% | -919.79% |
| EBIT | 87.31% | 35.23% | 57.34% | 24.79% | -650.35% |
| EBITDA | 1,742.75% | 307.79% | 107.94% | 270.80% | -107.99% |
| EPS Basic | 66.48% | 51.96% | -238.29% | 17.07% | -597.22% |
| Normalized Basic EPS | 91.53% | 18.97% | 2.62% | 52.63% | -372.00% |
| EPS Diluted | 66.48% | 55.00% | -238.29% | 17.07% | -597.22% |
| Normalized Diluted EPS | 91.53% | 18.97% | 2.11% | 53.51% | -372.00% |
| Average Basic Shares Outstanding | 0.87% | 9.93% | 18.32% | 63.95% | 63.93% |
| Average Diluted Shares Outstanding | 0.87% | 9.82% | 17.75% | 66.03% | 63.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |